论文部分内容阅读
为评价上皮性卵巢癌患者体外耐药(EDR)测定结果与一线紫杉醇(paclitaxel)、顺铂化疗疗效的相关性进行研究。 1995年3月~1997年10月,Roswell Park癌症研究所及Buffalo纽约州大学对首次行肿瘤细胞减灭术的100例卵巢癌的肿瘤标本进行EDR测定。
To evaluate the relationship between the results of in vitro drug resistance (EDR) and the efficacy of first-line paclitaxel and cisplatin chemotherapy in patients with epithelial ovarian cancer. March 1995 to October 1997, Roswell Park Cancer Institute and Buffalo University of New York on the first line of tumor cytoreductive surgery in 100 cases of ovarian cancer tumor specimens for EDR determination.